IP Library Granted Patent US 7,344,850
Granted Patent B2
US 7,344,850 · App. 10/748,335 · Granted Mar 18, 2008

Identification of active-site inhibitors of glycosyltransferases using a generalizable high-throughput screen

Assignee: Princeton University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,344,850
App. No.
10/748,335
Granted
Mar 18, 2008
Kind
B2
Abstract

A method is described for identifying a compound that modulates the ability of a glycosyltransferase to bind a substrate comprising combining a glycosyltransferase, a labeled substrate, and a compound, in a reaction vessel, under conditions known to be suitable for the glycosyltransferase to bind the labeled substrate, measuring an amount of labeled substrate bound to the glycosyltransferase, and comparing the amount to a standardized amount to identify a relative increase or decrease in substrate bound glycosyltransferase, thereby identifying a compound that modulates the ability of the glycosyltransferase to bind the substrate. A composition comprising an effective amount of a compound of Formula I (the substituents of which are described herein), or a stereoisomer, or pharmaceutically acceptable salt thereof, that inhibits the ability of a glycosyltransferase to bind a substrate, in a pharmaceutically acceptable carrier is provided

Claims (13)

1. A method of identifying a compound that inhibits the ability of a glycosyltransferase to bind a substrate comprising:

combining a glycosyltransferase, a labeled substrate, and a compound, in a reaction vessel, under conditions known to be suitable for the glycosyltransferase to bind the labeled substrate,

measuring the amount of labeled substrate bound to the glycosyltransferase, and comparing the amount to a standardized amount to identify a relative increase or decrease in substrate bound glycosyltransferase, thereby identifying a compound that modulates the ability of the glycosyltransferase to bind the substrate, wherein the glycosyltransferase is a GT-A or GT-B, NDP-glycosyltransferase, the label is fluorescein and, the labeled substrate is the UDP-GlcNAc (hexose donor) analogue:

2. A method of identifying a compound that inhibits the ability of a nucleotide-sugar glycosyltransferase to bind a substrate by performing a donor displacement assay comprising: combining in a reaction vessel, under conditions known to be suitable for the glycosyltransferase to bind substrate, a glycosyltransferase, a compound, and a glycosyl donor, wherein at least one substituent on the glycosyl group of said glycosyl donor can be modified to incorporate a label without abolishing binding of the donor to the glycosyltransferase, measuring the amount of labeled glycosyl donor bound to the glycosyltransferase, and comparing the amount to a standardized amount to identify a relative increase or decrease in glycosyl donor bound to the glycosyltransferase, thereby identifying a compound that modulates the ability of the glycosyltransferase to bind the glycosyl donor.

3. The method of claim 2 wherein the donor displacement assay is based on displacement of a fluorescently labeled glycosyl donor.

4. The method of claim 2 wherein the donor displacement assay is based on displacement of a ligand from the glycosyl donor binding site.

5. The method according to claim 2 wherein the glycosyltransferase is a GT-A or GT-B, NDP-glycosyltransferase.

6. The method according to claim 2 wherein the substrate comprises UDP, TDP or GDP.

7. The method according to claim 2 wherein the substrate comprises UDP-GlcNac.

8. The method according to claim 2 wherein the glycosyltransferase is MurG.

9. The method according to claim 2 wherein the label is selected from the group consisting of a chromophore, a fluorophore, a dye, a radioisotope and an enzyme.

10. The method according to claim 9 wherein the label is a fluorophore.

11. The method according to claim 10 wherein the fluorophore is fluorescein.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE SIGNATURE OF THE CONVEYING PARTY PREVIOUSLY RECORDED ON REEL 037794 FRAME 0022. ASSIGNOR(S) HEREBY CONFIRMS THE EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE. Recorded Feb 26, 2016
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 037928/0414 →
CONFIRMATORY LICENSE Recorded Feb 23, 2016
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 037794/0022 →
CONFIRMATORY LICENSE Recorded Dec 7, 2015
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037223/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2008
From: KAHNE, SUZANNE WALKER; KAHNE, DANIEL
To: PRINCETON UNIVERSITY
Reel/Frame 020381/0788 →
Continuity (1)
Related Publication 20050142629A1 · Jun 30, 2005